Washington Trust Bank’s Eli Lilly LLY Stock Holding History

Washington Trust Bank’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.6M	Sell	16,334 -1,193	-7%	-$1.22M	1.37%	17
2026 Q1	$16.1M	Buy	17,527 +9,887	+129%	+$10M	1.19%	23
2025 Q4	$8.21M	Sell	7,640 -67	-0.9%	-$64.1K	0.58%	42
2025 Q3	$5.88M	Buy	7,707 +728	+10%	+$542K	0.43%	52
2025 Q2	$5.44M	Sell	6,979 -102	-1%	-$79.3K	0.46%	53
2025 Q1	$5.85M	Sell	7,081 -531	-7%	-$442K	0.59%	47
2024 Q4	$5.88M	Buy	7,612 +108	+1%	+$89.4K	0.56%	50
2024 Q3	$6.65M	Sell	7,504 -5	-0.1%	-$4.5K	0.64%	46
2024 Q2	$6.8M	Sell	7,509 -135	-2%	-$108K	0.67%	43
2024 Q1	$5.95M	Sell	7,644 -2,001	-21%	-$1.42M	0.57%	52
2023 Q4	$5.62M	Sell	9,645 -37	-0.4%	-$21.6K	0.5%	56
2023 Q3	$5.2M	Hold	9,682	–	–	0.54%	51
2023 Q2	$4.54M	Buy	9,682 +1,882	+24%	+$789K	0.46%	52
2023 Q1	$2.68M	Hold	7,800	–	–	0.29%	64
2022 Q4	$2.85M	Buy	7,800 +9	+0.1%	+$3.19K	0.32%	66
2022 Q3	$2.52M	Sell	7,791 -552	-7%	-$175K	0.32%	69
2022 Q2	$2.71M	Sell	8,343 -137	-2%	-$41.1K	0.35%	64
2022 Q1	$2.43M	Sell	8,480 -257	-3%	-$66.1K	0.28%	67
2021 Q4	$2.41M	Sell	8,737 -6	-0.1%	-$1.52K	0.23%	66
2021 Q3	$2.02M	Sell	8,743 -7	-0.1%	-$1.73K	0.24%	65
2021 Q2	$2.01M	Sell	8,750 -134	-2%	-$26.9K	0.24%	64
2021 Q1	$1.66M	Sell	8,884 -51	-0.6%	-$9.98K	0.2%	72
2020 Q4	$1.51M	Sell	8,935 -12	-0.1%	-$1.79K	0.2%	73
2020 Q3	$1.32M	Buy	8,947 +34	+0.4%	+$5.26K	0.2%	73
2020 Q2	$1.46M	Sell	8,913 -10	-0.1%	-$1.53K	0.23%	67
2020 Q1	$1.24M	Sell	8,923 -530	-6%	-$72.8K	0.24%	65
2019 Q4	$1.24M	Sell	9,453 -20	-0.2%	-$2.32K	0.18%	89
2019 Q3	$1.06M	Sell	9,473 -696	-7%	-$77.5K	0.17%	83
2019 Q2	$1.13M	Sell	10,169 -120	-1%	-$14.1K	0.18%	81
2019 Q1	$1.33M	Sell	10,289 -430	-4%	-$52.3K	0.21%	77
2018 Q4	$1.24M	Sell	10,719 -432	-4%	-$48.3K	0.16%	98
2018 Q3	$1.2M	Sell	11,151 -284	-2%	-$28.4K	0.18%	84
2018 Q2	$976K	Sell	11,435 -1,152	-9%	-$94.6K	0.14%	98
2018 Q1	$974K	Sell	12,587 -1,627	-11%	-$131K	0.14%	92
2017 Q4	$1.2M	Buy	14,214 +585	+4%	+$49.8K	0.18%	89
2017 Q3	$1.17M	Buy	13,629 +3,260	+31%	+$267K	0.18%	82
2017 Q2	$853K	Hold	10,369	–	–	0.18%	85
2017 Q1	$872K	Buy	10,369 +4,990	+93%	+$400K	0.19%	83
2016 Q4	$396K	Sell	5,379 -248	-4%	-$18.5K	0.09%	128
2016 Q3	$452K	Sell	5,627 -1,491	-21%	-$119K	0.11%	109
2016 Q2	$561K	Buy	7,118 +509	+8%	+$38.3K	0.15%	101
2016 Q1	$476K	Sell	6,609 -450	-6%	-$34K	0.12%	105
2015 Q4	$595K	Sell	7,059 -2,720	-28%	-$226K	0.13%	115
2015 Q3	$818K	Hold	9,779	–	–	0.22%	92
2015 Q2	$816K	Buy	9,779 +150	+2%	+$11.4K	0.2%	87
2015 Q1	$700K	Hold	9,629	–	–	0.17%	100
2014 Q4	$664K	Buy	9,629 +384	+4%	+$25.9K	0.17%	116
2014 Q3	$600K	Sell	9,245 -4,255	-32%	-$269K	0.19%	111
2014 Q2	$839K	Buy	13,500 +1,800	+15%	+$107K	0.17%	100
2014 Q1	$689K	Buy	+11,700	New	+$653K	0.15%	106

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Washington Trust Bank's LLY Position: Q2 2026 in Review

Washington Trust Bank reduced its Eli Lilly (LLY) stake by 6.8% in Q2 2026, selling an estimated $1.22M and leaving 16,334 shares worth $19.6M. The position accounts for 1.37% of the portfolio, ranked #17.

Washington Trust Bank first reported a position in LLY in Q1 2014 and has held it in 50 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Washington Trust Bank held 16,334 shares of Eli Lilly worth $19.6M as of Q2 2026.
Washington Trust Bank sold 1,193 Eli Lilly shares in Q2 2026, an estimated $1.22M.
Eli Lilly made up 1.37% of Washington Trust Bank's portfolio in Q2 2026, its #17 holding.
Washington Trust Bank first reported a position in Eli Lilly in Q1 2014 and has held it in 50 quarters since.
4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Washington Trust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.